Accelerate Time-To-Market With a Proven Team of GI Experts

Tap into our extensive network of 5,000+ sites, leveraging exclusive data from central imaging projects in endoscopy and histopathology, and benefit from our team of medical and operational GI experts for swift study startup and accelerated patient recruitment.
In more than 60 countries
Supporting >70% of IBD compounds currently in development
Unrivaled KOL network

Therapeutic Focus

Alimentiv stands at the forefront of patient recruitment and imaging innovations for gastrointestinal and liver diseases, driving health breakthroughs through advanced research, accelerated clinical trials, and delivering actionable biomarker insights. We are dedicated to redefining the future of GI and liver clinical research.

Services

With over 30 years of pioneering advancements in gastrointestinal therapeutics, Alimentiv continues to advance clinical trials through medical research, development, and imaging solutions. Our team offers streamlined solutions for all stages of clinical development, from early phase 1 to phase 4 trials.


Latest Updates

Article Nov 1, 2024
Give Your Project Lift

With A Proven Quality By Design Framework Applying our Quality By Design framework in clinical trials saves time, money, and resources. These are crucial, precious,...

News Oct 12, 2024
Alimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease Challenges

Alimentiv, a full-service GI CRO and pioneer in IBD medical imaging solutions since 1986, is excited to announce the expansion of its partnership with Satisfai...

News Oct 11, 2024
Alimentiv Showcases End-to-End GI Research Solutions and Innovation With Four Poster Presentations at UEG Week 2024

London, Ontario, Canada, October 11, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce four poster presentations at the United European Gastroenterology (UEG) conference taking...

Speak to a member
of our expert team

Contact us